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Primary  duodenal  mucosa  associated  lymphoid  tissue  (MALT)  lymphoma  is  very  rare,  and  little  is  known  about  its 
clinical  course  or  effective  treatment.  We  describe  a  case  of  primary  duodenal  MALT  lymphoma  that  was  resistant  to 
Helicobacter  pylori  (H.  pylori)  eradication  and  regressed  after  chemotherapy  with  cyclophosphamide,  vincristine,  and 
prednisolone  (CVP).  A  71-year-old  woman  was  referred  to  our  department  because  of  epigastric  pain  and  dyspepsia. 
Gastroduodenoscopy  revealed  an  irregular  mucosal  nodular  lesion  with  ulceration  extending  from  the  bulb  to  the 
second  portion  of  the  duodenum.  Histopathological  examination  of  a  biopsy  specimen  disclosed  low-grade  MALT 
lymphoma  composed  of  atypical  lymphoid  cells  with  lymphoepithelial  lesion.  Abdominal  CT  scans  revealed  0.5  to  1.5 
cm  lymph  nodes  in  the  peritoneal  cavity,  suggestive  of  lymph  node  metastasis.  We  successfully  eradicated  H.  pylori 
but  did  not  see  signs  of  remission.  We  administered  systemic  CVP  chemotherapy  every  3  weeks.  After  6  courses  of 
CVP,  the  patient  achieved  complete  remission  and  was  followed  up  without  recurrence  for  about  a  year. 
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INTRODUCTION
Primary  lymphomas  of  the  gastrointestinal  tract  are  the  most 
common  type  of  extranodal  lymphoma,  accounting  for  less  than 
12%  of  all  non-Hodgkin's  lymphoma  (NHL)
1, 2).  The  majority  of 
these  lymphomas  arise  in  the  stomach,  with  less  than  30% 
arising  in  the  small  intestine.  Among  extranodal  NHL,  mucosa 
associated  lymphoid  tissue  (MALT)-derived  lymphoma  (MALT 
lymphoma)  was  recognized  as  a  distinct  clinicopathological 
entity  in  the  early  1980s,  and  can  arise  in  the  gastrointestinal 
tract,  lung,  eye,  salivary  gland,  and  thyroid  gland,  most  frequently 
in  the  stomach.  Gastric  MALT  lymphoma  is  associated  with 
Helicobacter  pylori  (H.  pylori)  infection,  and  the  eradication  of  H. 
pylori  correlates  with  tumor  regression
3, 4).  However,  MALT 
lymphoma  of  the  duodenum  is  very  rare,  and  little  is  known  about 
its  treatment  or  clinical  course.  Although  MALT  lymphoma 
regression  after  H.  pylori  eradication  has  been  sporadically 
reported
5, 6),  duodenal  MALT  lymphoma  may  be  resistant  to  H. 
pylori  eradication
7, 8).  In  the  current  paper,  we  describe  a  case  of 
primary  duodenal  MALT  lymphoma  that  was  resistant  to  H.  pylori 
eradication  and  regressed  after  chemotherapy  with  cyclophos-
phamide,  vincristine,  and  prednisolone  (CVP).
CASE REPORT
A  71-year-old  woman  was  referred  to  our  hospital  because 
of  dyspepsia  and  epigastric  pain  during  the  preceding  3  months. 
She  had  no  allergies  or  past  medical  history,  and  her  family 
history  was  unremarkable.  The  physical  examination  showed Kyung  Hee  Woo,  et  al  :  Duodenal  Mucosa-Associated  Lymphoid  Tissue  Lymphoma 297
 
Figure  1.  Gastroduodenoscopy.  The  initial  gastroduodenoscopy  reveals  irregular  nodular  mucosal  lesions  with  bleeding  ulcerations 
extending form the bulb to the second portion of the duodenum (A). After 6 courses of chemotherapy, the follow-up gastroduodenoscopy 
shows  complete  regression  of  duodenal  MALT  lymphoma  (B).
 
Figure  2.  Histological  examination  of  initial  biopsy  specimens  from  the  duodenal  lesion.  A.  Atypical  lymphoid  cells  invading  duodenal 
mucosa  (H&E  stain  ×100).  B.  A  lymphoepithelial  lesion  indicative  of  MALT  lymphoma  (H&E  stain,  ×200).
tenderness  in  the  epigastrium  but  no  peripheral  lympha-
denopathy,  hepatosplenomegaly,  or  intra-abdominal  mass. 
Laboratory  examinations  revealed  normal  blood  counts  and 
biochemistry  and  normal  serum  immunoglobulins.  Gastroduo-
denoscopy  revealed  irregular  nodular  mucosal  lesions  with 
bleeding  ulcerations  that  extended  from  the  bulb  to  the  second 
portion  of  the  duodenum  (Figure  1A).  Histopathological 
examination  of  a  biopsy  specimen  showed  low-grade  MALT 
lymphoma  composed  of  atypical  lymphoid  cells  with  a 
lymphoepithelial  lesion  (Figure  2),  positive  for  B-cell  surface 
marker  L26  (CD20)  and  negative  for  cyclin  D1,  CD3,  and 
CD45RO.  In  the  stomach,  endoscopy  and  histology  showed 
chronic  superficial  gastritis  associated  with  H.  pylori  infection. 
Hospitalization  was  recommended  for  staging  work-up,  but  she 
declined.  We  decided  to  eradicate  H.  pylori  by  treatment  with 
amoxicillin  (1000  mg  twice  daily),  pantoprazole  (40  mg  twice 
daily),  and  clarithromycin  (50  mg  twice  daily)  for  1  week.  Two 
months  after  the  completion  of  antibiotic  treatment,  however,  her 
symptoms  were  aggravated.  Gastroduodenoscopy  disclosed  no 
evidence  of  H.  pylori  in  the  gastric  mucosa,  but  no  sign  of 
regression  of  the  duodenal  lesion  was  observed. 
Thereafter,  the  patient  was  admitted  for  further  evaluation 
and  treatment  of  the  duodenal  MALT  lymphoma.  Chest  CT 
scans  showed  no  evidence  of  lymph  node  enlargement  in  the 
mediastinum.  Abdominal  CT  scans  revealed  0.5  to  1.5  cm 
lymph  nodes  in  the  peritoneal  cavity,  suggestive  of  lymph  node 
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Figure  3.  Abdominal  CT  scan  with  contrast.  Pre-treatment  abdominal  CT  scan  revealed  0.5  to  1.5  cm  lymph  nodes  (arrows)  in  the 
peritoneal  cavity,  suggestive  of  lymph  node  metastasis  (A,  C).  After  chemotherapy,  these  enlarged  lymph  nodes  disappeared  (B,  D).
metastasis  (Figure  3A).  Bone  marrow  biopsy  showed  no 
evidence  of  lymphoma  involvement.  The  patient  was  classified 
as  having  stage  EII2  MALT  lymphoma  according  to  the  Ann 
Arbor  classification  modified  by  Musshoff
9).  We  administered 
systemic  chemotherapy  with  cyclophosphamide,  vincristine,  and 
prednisolone  (CVP)  every  3  weeks,  which  was  well  tolerated 
except  for  transient  hair  loss,  and  epigastric  pain  resolved  after 
2  cycles  of  chemotherapy.  After  6  courses  of  CVP,  the  patient 
achieved  complete  remission  (CR)  (Figure  1B,  3B)  and  was 
followed  up  without  recurrence  for  about  a  year. 
DISCUSSION
Gastric  MALT  lymphoma  has  been  considered  to  boe 
preceded  by  the  acquisition  of  MALT  as  consequence  of  H. 
pylori  infection.  The  involvement  of  H.  pylori  in  the  pathogenesis 
of  monoclonal  lymphoid  proliferation  may  be  due  to  a  H. 
pylori-reactive  T-cell-mediated  reaction
10).  In  contrast  to  gastric 
MALT  lymphoma,  the  relationship  between  duodenal  MALT   
lymphoma  and  H.  pylori  infection  has  not  been  established.  For 
duodenal  MALT  lymphoma,  H.  pylori  eradication  may
5, 6)  or  may 
not
7, 8)  lead  to  lymphoma  regression.  Here,  H.  pylori  eradication 
did  not  cure  duodenal  MALT  lymphoma. 
Lepicard  et  al.  reported  four  cases  of  duodenal  MALT 
lymphoma  treated  with  oral  cyclophophamide  (100  mg  per  day) 
for  18  months
11).  Tumor  infiltration  was  limited  to  the  duodenal 
wall  in  one  case  and  was  associated  with  locoregional 
lymphadenopathies  in  three  cases.  Three  patients  achieved  CR 
and  one  achieved  partial  remission.  However,  two  of  the  four 
patients  with  CR  showed  relapse  microscopically  after  2  years. 
These  results  suggest  that  oral  cyclophosphamide  may  be  a 
reasonable  treatment  option  for  slowly  progressive  disease. 
However,  the  long-term  effects  of  this  treatment  strategy  and 
the  best  approach  to  relapse  remain  to  be  determined.  Ochi  et 
al.  reported  regression  of  the  MALT  lymphoma  confined  from 
mucosa  to  submucosa  of  the  duodenum  after  long-term 
treatment  with  clarithromycin
12),  which  may  have  resulted  from 
inhibition  of  lymphocyte  activation.  On  the  other  hand,  Ventrucci 
et  al.  reported  a  case  of  primary  MALT  lymphoma  of  the  papilla 
CD
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of  vater  that  regressed  after  eight  monthly  courses  of  CVP
13).  In 
our  case,  H.  pylori  eradication  did  not  lead  to  lymphoma 
regression.  Abdominal  CT  scans  suggesting  involvement  of 
lymph  nodes  in  the  peritoneal  cavity  and  the  aggravation  of 
symptoms  prompted  the  use  of  systemic  chemotherapy  with  6 
cycles  of  CVP,  which  was  well  tolerated  and  led  to  CR. 
To  the  best  of  our  knowledge,  this  is  the  first  case  report  of 
a  duodenal  MALT  lymphoma  that  showed  complete  remission 
with  CVP  chemotherapy.  Given  the  indolent  nature  of  this 
tumor,  monotherapy  with  cyclophosphamide  or  clarithromycin 
may  be  a  reasonable  option  for  MALT  lymphoma  confined  to 
the  mucosa  or  submucosa  of  the  duodenum.  However, 
systemic  chemotherapy  may  be  optimal  when  there  is 
locoregional  lymph  node  involvement. 
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